A metagenomic study of the gut microbiome in Behcet's disease/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by ChiomaBlessing on 2024-3-29

Curated date: 2024/03/08

Curator: Fiddyhamma

Revision editor(s): Fiddyhamma, ChiomaBlessing

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Behcet's syndrome Adamantiades-Behcet disease,BD,Bechet syndrome,BEHCET DIS,Behcet Disease,Behcet disease,Behcet syndrome,Behcet's disease,Behcet's syndrome,Behcets Syndrome,Behet's syndrome,Behet's syndrome (disorder),Behçet disease,Behçet syndrome,Behçet's disease,Behçet's syndrome,Behçet-Adamantiades syndrome,Behçet’s disease,Morbus Behçet's syndrome,silk road disease,triple symptom complex,Triple-Symptom Complex,behcet's syndrome
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Control
Group 1 name Corresponds to the case (exposed) group for case-control studies
Untreated active Behcet's disease (BD) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Active BD was defined according to presence of active intraocular inflammation (case-control)
Group 0 sample size Number of subjects in the control (unexposed) group
52
Group 1 sample size Number of subjects in the case (exposed) group
24
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
1 month

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2
Matched on Factors on which subjects have been matched on in a case-control study
age, body mass index, sex


Signature 1

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-3-29

Curated date: 2024/03/08

Curator: Fiddyhamma

Revision editor(s): Fiddyhamma, Welile, ChiomaBlessing

Source: Figure 2a

Description: Differentially abundant genera in Behcet's disease subjects compared to healthy controls.

Abundance in Group 1: increased abundance in Untreated active Behcet's disease (BD) patients

NCBI Quality ControlLinks
Alistipes ihumii
Alistipes sp. HGB5
Azospirillum sp. CAG:239
Bacteroides
Bacteroides eggerthii CAG:109
Bacteroides sp. CAG:770
Bilophila sp. 4_1_30
Bilophila wadsworthia
Collinsella aerofaciens
Collinsella sp. 4_8_47FAA
Collinsella sp. CAG:166
Eubacterium sp. CAG:202
Firmicutes bacterium CAG:240
Firmicutes bacterium CAG:83
Fusobacterium sp. CAG:815
Mitsuokella multacida
Oscillibacter sp. KLE 1728
Oscillibacter sp. KLE 1745
Oscillospiraceae bacterium VE202-24
Paraprevotella clara CAG:116
Phocaeicola coprophilus CAG:333
Ruminococcaceae bacterium cv2
uncultured crAssphage

Revision editor(s): Fiddyhamma, Welile, ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-3-29

Curated date: 2024/03/08

Curator: Fiddyhamma

Revision editor(s): Fiddyhamma, ChiomaBlessing

Source: Figure 2a

Description: Differentially abundant genera in Behcet's disease subjects compared to healthy controls.

Abundance in Group 1: decreased abundance in Untreated active Behcet's disease (BD) patients

NCBI Quality ControlLinks
Acidiphilium sp. CAG:727
Alistipes sp. CAG:268
Anaerotruncus sp. CAG:528
Clostridium sp. CAG:1024
Clostridium sp. CAG:127
Clostridium sp. CAG:349
Clostridium sp. CAG:813
Coprococcus sp. CAG:782
Dialister invisus
Eubacterium sp. CAG:38
Fusobacterium mortiferum
Megasphaera elsdenii CAG:570
Methanoculleus sp. CAG:1088
Methanomethylophilus alvi
Pyramidobacter piscolens
Subdoligranulum sp. CAG:314

Revision editor(s): Fiddyhamma, ChiomaBlessing